| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| FOSTER JAMES C | Chairman, President and CEO, Director | C/O CHARLES RIVER LABORATORIES, 251 BALLARDVALE STREET, WILMINGTON | /s/ James C. Foster | 04 Mar 2026 | 0001141722 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | CRL | Common Stock | Award | +16,796 | +6.4% | $178.61* | 279,693 | 02 Mar 2026 | Direct | F1, F2 | |
| holding | CRL | Common Stock | 5,423 | 02 Mar 2026 | 2024 GRAT | ||||||
| holding | CRL | Common Stock | 10,780 | 02 Mar 2026 | 2025 GRAT | ||||||
| holding | CRL | Common Stock | 230 | 02 Mar 2026 | by Trust | ||||||
| holding | CRL | Common Stock | 750 | 02 Mar 2026 | By Trust | ||||||
| holding | CRL | Common Stock | 2,250 | 02 Mar 2026 | By Trust | ||||||
| holding | CRL | Common Stock | 10,000 | 02 Mar 2026 | Held By Spouse |
| Id | Content |
|---|---|
| F1 | 100% of the unvested restricted stock units vest on March 2, 2028. |
| F2 | Reflects the exempt transfer pursuant to Rule 16a-13 of 9,220 shares from the 2025 GRAT account to direct holdings. |